MabVax PET imaging agent MVT-2163 shows robust lesion uptake in early-stage study; shares ahead 22% premarket

from Stock Market News http://ift.tt/2tlXKpP

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s